Palantir's NHS Contract Defended Amid Calls for Cancellation
Palantir boss says calls for tech firm to be dumped from NHS are 'irresponsible' and could harm patient care

Image: Mail Online
Louis Mosley, UK head of Palantir, argues against calls to terminate the company's £330 million NHS contract, stating it improves patient care. A recent report by MPs questioned Palantir's role in public services, but Mosley emphasized the company's positive impact on NHS operations and patient outcomes.
- 01Palantir's NHS contract is valued at £330 million and has reportedly facilitated 110,000 additional operations.
- 02The science and technology committee's report criticized Palantir's involvement in public services but acknowledged its results.
- 03Mosley highlighted a 15% drop in discharge delays and a 6.8% increase in timely cancer diagnoses since the platform's implementation.
- 04Palantir's contract was awarded after a competitive process, deemed the best fit for NHS needs.
- 05The controversy surrounding Palantir is partly due to its founder's political affiliations and the company's work with US immigration enforcement.
Advertisement
In-Article Ad
Louis Mosley, the UK head of Palantir, has defended the company's £330 million contract with the NHS, asserting that terminating it would be 'irresponsible' as it has significantly improved patient care. Following a report from the science and technology committee calling for the cancellation of Palantir's contract due to concerns over its involvement in US immigration enforcement and ties to the Israeli military, Mosley emphasized the positive outcomes achieved through their technology. He noted that since the introduction of Palantir's data platform, the NHS has seen an increase of 110,000 operations, a 15% reduction in discharge delays, and a 6.8% rise in cancer diagnoses within 28 days. Mosley criticized MPs for not proposing alternatives and pointed out that Palantir was selected through a competitive bidding process. The controversy is compounded by Palantir's founder, Peter Thiel's, political connections and the company's broader public sector contracts in the UK.
Advertisement
In-Article Ad
The continuation of Palantir's contract is crucial for maintaining current levels of patient care and operational efficiency within the NHS.
Advertisement
In-Article Ad
Reader Poll
What do you think about Palantir's involvement in the NHS?
Connecting to poll...
More about NHS
Read the original article
Visit the source for the complete story.






